ACE2 has been reported to be a tumor suppressor gene in diverse cancers, however, in breast invasive and thyroid carcinoma, in prostate cancer, liver hepatocellular carcinoma, kidney chromophobe, and stomach adenocarcinoma it was considered an oncogene [15]. This evidence concerns the gene ACE2 and prostate cancer.